about
Semienzymatic Cyclization of Disulfide-rich Peptides Using Sortase AAnticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targetingCyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent MechanismA novel quantitative kinase assay using bacterial surface display and flow cytometryPhosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.Cyclotide interactions with the nematode external surface.Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels.Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.The biological activity of the prototypic cyclotide kalata b1 is modulated by the formation of multimeric poresOptimization of the cyclotide framework to improve cell penetration properties.Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activitiesDesign of substrate-based BCR-ABL kinase inhibitors using the cyclotide scaffold.Structural and functional characterization of chimeric cyclotides from the Möbius and trypsin inhibitor subfamilies.Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold.High-affinity cyclic peptide matriptase inhibitorsLengths of the C-Terminus and Interconnecting Loops Impact Stability of Spider-Derived Gating Modifier Toxins.Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep.Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria.Understanding the Diversity and Distribution of Cyclotides from Plants of Varied Genetic Origin.Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions.The Prototypic Cyclotide Kalata B1 Has a Unique Mechanism of Entering Cells.Fmoc-based synthesis of disulfide-rich cyclic peptides.The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability.Synthesis, Racemic X-ray Crystallographic, and Permeability Studies of Bioactive Orbitides from Jatropha SpeciesEnhanced Activity against Multidrug-Resistant Bacteria through Coapplication of an Analogue of Tachyplesin I and an Inhibitor of the QseC/B Signaling PathwayCircular Permutation of the Native Enzyme-Mediated Cyclization Position in CyclotidesCell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor PropertiesCharacterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer PropertiesDiscovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus
P50
Q27681346-E7339E2C-3C1F-4B0A-838E-7F88120E4348Q27694726-4ABEF5F1-86CE-4001-B842-1FE0D424BA5BQ28534321-3F3369F2-09B7-492B-BA5D-E191DCDDF7B5Q28535179-F6CABF72-F0AE-4230-8891-FDBCA5F43C5FQ30525336-F4BD0DD4-62A2-4B57-80C5-32F84C1C6091Q33826390-27BDE46B-DD44-43FF-A8DA-A8E6DA40EDF9Q33842774-65DE207F-8060-4C6F-9E69-FBBBEBF85544Q34004482-82A568BF-32FC-4847-B88C-A5CA4294512EQ34984555-3EBA420A-A1A3-42C5-A466-00F7517D8E9EQ35063455-CC8DB434-7E17-4166-9780-36176D3E69E9Q35085127-5F322D1E-5B28-4699-8EDB-44433F74F479Q35942258-72371316-B6DC-476A-805E-A6A6A0A1A6A1Q38834923-A3CFD2BE-2833-48CD-8CE2-3D65AD100675Q40065016-5A9F0A0B-9922-44C1-A453-5B2B0DDE66F4Q40601659-DAE63F15-6FE2-4486-8C0D-0D11A005408DQ41569702-A7CB3BB3-3989-4371-B7C7-CC149A050DA4Q42163975-4B00C8D8-15A3-4F7A-90B4-1A37490ED2E1Q44962831-A26B0EBE-8B9E-4AEE-9373-E19B4DF20784Q46371953-F96E3E1C-48D3-43ED-AD59-E8080462F263Q47886865-10A676F7-3DF0-4298-9EC8-D218CD77CD24Q48030895-D9562116-69AA-4373-A7B3-EA6AF87E2670Q51708849-A8C8BAF5-CCB5-4861-BD97-DBD6C32CEBCDQ51807255-ED95EAA7-3D5F-4432-BF55-24A7930CD194Q53042942-0BED2189-D8D9-4332-897A-2415CD0C3199Q54303879-42C0E542-2622-45B4-8690-50B5C6B31676Q57803979-CFFEF193-FE73-49E7-B163-689381088818Q89463998-63FCEF0F-D5D0-4A01-B946-12BB7CFB1E57Q90593259-24E4351A-A985-44A1-965F-C18CA8CD3578Q92474860-D71A7030-CB08-43B5-8CF8-78BF4DD1070DQ92906753-A7C264F6-71B8-443E-8C25-E21E74337F80Q94947772-0BDF461B-739D-4BAD-BF9E-9E666A7CD2F7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yen-Hua Huang
@ast
Yen-Hua Huang
@en
Yen-Hua Huang
@es
Yen-Hua Huang
@nl
Yen-Hua Huang
@sl
type
label
Yen-Hua Huang
@ast
Yen-Hua Huang
@en
Yen-Hua Huang
@es
Yen-Hua Huang
@nl
Yen-Hua Huang
@sl
prefLabel
Yen-Hua Huang
@ast
Yen-Hua Huang
@en
Yen-Hua Huang
@es
Yen-Hua Huang
@nl
Yen-Hua Huang
@sl
P1053
J-9056-2014
P106
P1153
56980702600
P31
P3829
P496
0000-0001-6937-2660